§35.2075. Records of the release of individuals containing unsealed byproduct material or implants containing byproduct material.
10 C.F.R. § 35.2075
A licensee shall retain a record of the basis for authorizing the release of an individual in accordance with § 35.75, if the total effective dose equivalent is calculated by—
Using the retained activity rather than the activity administered;
Using an occupancy factor less than 0.25 at 1 meter;
Using the biological or effective half-life; or
Considering the shielding by tissue.
A licensee shall retain a record that the instructions required by § 35.75(b) were provided to a breast-feeding female if the radiation dose to the infant or child from continued breast-feeding could result in a total effective dose equivalent exceeding 5 mSv (0.5 rem).
The records required by paragraphs (a) and (b) of this section must be retained for 3 years after the date of release of the individual.
Notes, amendments, and revision history
Authority
Authority: Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (42 U.S.C. 2111, 2201, 2231, 2232, 2233, 2273, 2282, 2021); Energy Reorganization Act of 1974, secs. 201, 206 (42 U.S.C. 5841, 5846); 44 U.S.C. 3504 note.
Source
Source: 67 FR 20370, Apr. 24, 2002, unless otherwise noted.